Background. Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by bone erosions and new bone formation. MicroRNAs (miRNAs) are key regulators of the immune responses. Differential expression of miRNAs has been reported in several inflammatory autoimmune diseases; however, their role in PsA is not fully elucidated. We aimed to identify miRNA expression signatures associated with PsA and to investigate their potential implication in the disease pathogenesis. Methods. miRNA microarray was performed in blood cells of PsA patients and healthy controls. miRNA pathway analyses were performed and the global miRNA profiling was combined with transcriptome data in PsA. Deregulation of selected miRNAs was validated by real-time PCR....
Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses an...
MicroRNAs (miRNAs) are small non-coding RNA molecules, which function in RNA silencing and post-tran...
Inter-individual variability in clinical efficacy of different biological treatments in psoriatic pa...
Background. Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by bone erosions a...
OBJECTIVES: To evaluate the micro-RNA (miRNA) expression profile in patients with early psoriatic a...
Background MicroRNAs (miRNAs) gene expression regulators are altered in psoriasis suggesting their r...
Background. Psoriasis is an immune-mediated inflammatory chronic skin disease characterized by chron...
Psoriasis is an immune-mediated skin disease which affects 2-4% of the worldwide population. Approxi...
MicroRNAs (miRNAs) are small non-coding RNAs that have emerged as central regulators of gene express...
<p>Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses...
<p>Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses...
In this article we summarize the new acquisitions about the growing importance of miRNAs in rheumati...
Psoriasis is the most common chronic skin inflammation in adults which affects 2-4% of the world pop...
In psoriatic arthritis (PsA), progressive bone destruction is mediated by monocyte-derived osteoclas...
Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses an...
Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses an...
MicroRNAs (miRNAs) are small non-coding RNA molecules, which function in RNA silencing and post-tran...
Inter-individual variability in clinical efficacy of different biological treatments in psoriatic pa...
Background. Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by bone erosions a...
OBJECTIVES: To evaluate the micro-RNA (miRNA) expression profile in patients with early psoriatic a...
Background MicroRNAs (miRNAs) gene expression regulators are altered in psoriasis suggesting their r...
Background. Psoriasis is an immune-mediated inflammatory chronic skin disease characterized by chron...
Psoriasis is an immune-mediated skin disease which affects 2-4% of the worldwide population. Approxi...
MicroRNAs (miRNAs) are small non-coding RNAs that have emerged as central regulators of gene express...
<p>Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses...
<p>Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses...
In this article we summarize the new acquisitions about the growing importance of miRNAs in rheumati...
Psoriasis is the most common chronic skin inflammation in adults which affects 2-4% of the world pop...
In psoriatic arthritis (PsA), progressive bone destruction is mediated by monocyte-derived osteoclas...
Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses an...
Psoriatic arthritis (PsA) is an inflammatory arthritis, characterized by inflammation of entheses an...
MicroRNAs (miRNAs) are small non-coding RNA molecules, which function in RNA silencing and post-tran...
Inter-individual variability in clinical efficacy of different biological treatments in psoriatic pa...